Skip to Content

Clotrimazole Pregnancy and Breastfeeding Warnings

Clotrimazole is also known as: Clotrimazole Troche, Mycelex Troche

Medically reviewed on December 15, 2017

Clotrimazole Pregnancy Warnings

Animal models have revealed evidence of embryotoxicity, impairment in mating, lower numbers of viable young, and decreased survival to weaning at potentially maternally toxic doses when given 9 weeks before mating through weaning. There are no controlled data in human pregnancy.

US FDA pregnancy category C: Animal reproduction studies have shown an adverse effect on the fetus and there are no adequate and well-controlled studies in humans, but potential benefits may warrant use of the drug in pregnant women despite potential risks.

This drug should be used during pregnancy only if the benefit outweighs the risk to the fetus.

US FDA pregnancy category: C

See references

Clotrimazole Breastfeeding Warnings

The manufacturer makes no recommendation regarding use during lactation.

Excreted into human milk: Data not available
Excreted into animal milk: Data not available

Comments: The effects in the nursing infant are unknown.

See references

References for pregnancy information

  1. "Product Information. Mycelex (clotrimazole)." Bayer, West Haven, CT.

References for breastfeeding information

  1. "Product Information. Mycelex (clotrimazole)." Bayer, West Haven, CT.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide